Abstract:ObjectivesProstate cancer (PCa) diagnosis still relies on 12-core systematic biopsy (SBx). More recently, pre-biopsy multiparametric MRI has been introduced in the guidelines as a valuable imaging tool for the detection of significant PCa. However, poor reproducibility and specificity, along with its high cost and limited availability, evidence the need for cost-effective, widespread imaging alternatives. 3D contrast-enhanced ultrasound (CEUS) has shown promise for PCa localization by extraction of quantitative perfusion and dispersion features associated with cancer angiogenesis. Tissue stiffness is an additional PCa biomarker that can be quantified by ultrasound shear-wave elastography (SWE). In this study, the diagnostic potential of multiparametric ultrasound imaging, combining 3D CEUS and SWE features, was evaluated for PCa localization by comparison with the corresponding SBx outcome.MaterialsAfter signing an informed consent, 54 biopsy-naïve patients underwent a 3D CEUS recording using a LOGIQ E9 scanner (GE HealthCare, USA) and a multi-plane (probe sweep) 2D SWE scan using an Aixplorer scanner (SuperSonic Imagine, France) at the Second Affiliated Hospital of Zhejiang University (China). All patients received SBx. Multiple 3D perfusion and dispersion feature maps were extracted from the 3D CEUS acquisitions and further complemented with 3D maps of tissue stiffness, reconstructed based on the multi-plane 2D SWE acquisitions. Subsequently, all the 3D maps were subdivided in 12 regions corresponding to the SBx locations. Gradient Boosting (GB) classification was then implemented together with sequential floating forward feature selection for prediction of the biopsy outcome. The classification accuracy was assessed by a k-fold cross-validation procedure.ResultsOf the 54 patients, 20 had SBx-proven significant PCa. Prediction of biopsy outcome using only CEUS features produced an area under the receiver-operating-characteristic curve (AUC) of 0.81, while using the SWE elasticity alone produced an AUC of 0.66. Their combination yielded an improved AUC of 0.85.ConclusionsThe proposed 3D multiparametric ultrasound imaging approach yields accurate PCa classification results, showing promise for cost-effective PCa localization by multiparametric ultrasound imaging. A multicenter trial has recently started to validate and optimize the classification performance in a larger patient cohort.

Advanced ultrasound in the diagnosis of prostate cancer

3-D Multi-parametric Contrast-Enhanced Ultrasound for the Prediction of Prostate Cancer.

PREDICTION OF PROSTATE BIOPSY OUTCOME BY MULTIPARAMETRIC ULTRASOUND IMAGING

Can 3D Multiparametric Ultrasound Imaging Predict Prostate Biopsy Outcome?

Multiparametric Ultrasound and Machine Learning for Prostate Cancer Localization

3D multiparametric contrast ultrasound predicts the histopathological outcome of systematic biopsy

Prostate Cancer Diagnosis with Micro-ultrasound: What We Know now and New Horizons

3-D Quantitative Dynamic Contrast Ultrasound for Prostate Cancer Localization.

Advanced Imaging for Localized Prostate Cancer

Prostate Cancer Ultrasound: Is Still a Valid Tool?

Non-Invasive Diagnosis of Prostate Cancer and High-Grade Prostate Cancer Using Multiparametric Ultrasonography and Serological Examination

Micro-Ultrasound: Current Role in Prostate Cancer Diagnosis and Future Possibilities

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

Transrectal Ultrasound Examination of Prostate Cancer Guided by Fusion Imaging of Multiparametric MRI and TRUS: Avoiding Unnecessary Mpmri-Guided Targeted Biopsy

The Combined Value of Mpus and Mpmri-Trus Fusion for the Diagnosis of Clinically Significant Prostate Cancer.

Diagnostic Accuracy of Qualitative and Quantitative Magnetic Resonance Imaging-Guided Contrast-Enhanced Ultrasound (Mri-Guided CEUS) for the Detection of Prostate Cancer: a Prospective and Multicenter Study

Comparative diagnostic accuracy of multiparametric magnetic resonance imaging-ultrasound fusion-guided biopsy versus systematic biopsy for clinically significant prostate cancer

Emerging MR methods for improved diagnosis of prostate cancer by multiparametric MRI

Evaluating Prostate Cancer: The Diagnostic Impact of MRI and Its Relationship With Transrectal Ultrasound (TRUS)-Guided Biopsy

Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics

Improving diagnostic efficacy of primary prostate cancer with combined 99mTc-PSMA SPECT/CT and multiparametric-MRI and quantitative parameters